トロンボエラストグラフィの世界市場

トロンボエラストグラフィの世界市場は2030年までに9億3,310万米ドルに達する見込み

2024年に6億7,210万米ドルと推定されるトロンボエラストグラフィの世界市場は、2024年から2030年にかけてCAGR 5.6%で成長し、2030年には9億3,310万米ドルに達すると予測されます。本レポートで分析したセグメントの1つである標準トロンボエラストグラフィは、CAGR 7.3％を記録し、分析期間終了時には2億8,240万米ドルに達すると予測されています。Rapid TEGセグメントの成長率は、分析期間でCAGR 4.2％と推定されます。

米国市場は1億8,310万米ドルと推定、中国はCAGR9.2％で成長予測

米国のトロンボエラストグラフィ市場は、2024年に1億8,310万米ドルと推定されます。世界第2位の経済大国である中国は、2024年から2030年の分析期間においてCAGR 9.2％をたどり、2030年には1億9,100万米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ2.6%と5.6%と予測されています。欧州では、ドイツがCAGR 3.7%で成長すると予測されています。

世界の「トロンボエラストグラフィ」市場- 主要動向と促進要因のまとめ

トロンボエラストグラフィはクリティカルケアにおける止血検査をどのように再定義しているか？

トロンボエラストグラフィ（TEG）は、凝固プロセス全体をダイナミックかつリアルタイムに評価することで、従来の凝固アッセイを超え、臨床医が止血を評価する方法に革命をもたらしています。凝固カスケードの孤立点を評価するPT、aPTT、INRのような従来の検査項目とは異なり、TEGは血栓の形成、安定化、溶解を包括的に評価します。このリアルタイムの評価は、血液製剤の投与に関する迅速で正確な決定が救命につながる、外傷、心臓手術、肝移植、集中治療環境において特に有用です。血液が凝固する際の粘弾性特性を追跡することにより、TEGは臨床医が出血の原因が血小板機能不全、フィブリノゲン欠乏、または線溶亢進のいずれによるものかを突き止めることを可能にします。その結果、患者の転帰を改善しながら、血小板、血漿、凍結沈殿物の不必要な使用を減らす個別化された輸血戦略が可能となります。輸血関連合併症（TRALIや免疫変調症など）のリスクに対する認識が高まるにつれ、病院はより正確で的を絞った凝固モニタリングを採用するようになり、TEGシステムはこのような患者別止血療法へのシフトにおける有力な技術として台頭してきています。

トロンボエラストグラフィは外科および救急医療における新しい標準となり得るか？

トロンボエラストグラフィの臨床的汎用性は、出血性合併症が一般的で、一刻を争う決断が不可欠な外科手術や救急医療における新しい標準治療として位置づけられています。凝固異常が複雑で多因子にわたることが多い心臓や肝臓の手術において、TEGは消費性凝固異常と希釈性凝固異常を区別するのに必要なきめ細かさを提供し、的確な介入を可能にします。ワルファリン、DOAC、ヘパリンのいずれを使用しているかにかかわらず、抗凝固療法を受けている患者の管理におけるTEGの有用性は、術前スクリーニングと術中モニタリングの両方において価値あるツールとなります。救急部門も外傷患者の管理でTEGを利用しており、そこではTEGによる洞察に基づいて大量輸血プロトコールが最適化され、罹患率と死亡率の両方が減少しています。産科センターでは分娩後出血、特に子癇前症やHELLP症候群の場合の出血リスクを評価するためにTEGを使用しています。一方、集中治療室（ICU）では、敗血症、播種性血管内凝固症候群（DIC）、COVID-19関連凝固障害を有する患者の継続的な凝固評価にTEGを取り入れています。医療分野全体に広く適用可能であることと、データ駆動型の迅速な意思決定に対する要求が、TEGを用いたリアルタイムの凝固診断へのシフトを促しています。

トロンボエラストグラフィはどのような技術的強化によって能力を拡大していますか？

トロンボエラストグラフィ技術における最近の進歩は、システムをより使いやすく、正確で、様々な臨床環境に適応できるものにしています。最新のTEGアナライザーは、自動化されたサンプルハンドリング、タッチスクリーンインターフェース、統合された品質管理を特徴とし、技術者のミスを減らし、安定した結果を可能にします。ポータブルおよびポイントオブケア（POC）TEGシステムは、リアルタイムの凝固モニタリングへのアクセスを三次病院だけでなく、小規模の外科センター、救急車、および野戦病院にも拡大しています。ソフトウェアのアップグレードにより、高度な分析、クラウドベースのデータ共有、電子カルテ（EHR）への統合が可能になり、結果を迅速に解釈して集学的治療に効果的に活用できるようになりました。カートリッジ式の検査システムもあり、手作業によるピペッティングの必要性をなくし、感染症発生時のバイオセーフティーを強化しています。メーカーはまた、診断の特異性を向上させ、抗凝固剤逆転戦略を導くために、多重アッセイやバイオマーカー統合を模索しています。臨床トレーニングの増加やアルゴリズムベースの意思決定支援ツールと相まって、これらの強化は学習曲線を減少させ、臨床医がリアルタイムの治療判断にTEGの洞察を取り入れるのを助け、それによってますます多様化するヘルスケア環境においてその有用性を拡大しています。

トロンボエラストグラフィ市場の成長はいくつかの要因によって牽引されています。

トロンボエラストグラフィの採用が増加している主な要因は、高リスクの外科手術、外傷治療、重症患者管理におけるトロンボエラストグラフィの臨床的意義の高まりです。心血管疾患、肝疾患、外傷の世界の負担の増加（特に新興国）により、止血評価や輸血管理のより正確なツールが必要とされています。さらに、手術件数の増加や低侵襲手術の複雑化に伴い、正確な術中凝固モニタリングの必要性が高まっています。病院はコスト抑制と輸血関連合併症の回避の両面から血液製剤使用量の削減を迫られており、TEGが可能にするような精密誘導輸血戦略の需要を押し上げています。これと並行して、高齢化社会における抗凝固療法と複雑な凝固異常の有病率の上昇は、凝固状態をリアルタイムで正確に評価できる技術に対するニーズを生み出しています。ポイントオブケア検査の動向と診断サービスの分散化もまた、TEGの採用を大病院から外来手術センターや救急対応ユニットへと拡大しています。自動化、可搬性、EHR統合などの技術的進歩は、使いやすさを向上させ、操作上の障壁を減らしています。一方、規制当局の承認と臨床ガイドラインの承認は、現代の臨床ワークフローにおけるTEGの価値を強化しています。テクノロジー、ヘルスケア提供、患者人口統計の各分野におけるこうした力学の収束が、世界のトロンボエラストグラフィ市場の急成長を後押ししています。

セグメント

タイプ（標準、迅速TEG、ネイティブTEG、ヘパリナーゼ、機能性フィブリノーゲン、血小板マッピング）、アプリケーション（心肺バイパス、肝臓外科、外傷外科、産科）、エンドユーザー（病院、血液銀行、学術機関、その他のエンドユーザー）

調査対象企業の例（合計 42注目）

• 5-Diagnostics GmbH
• Bio-Zircon
• Biomart
• Chongqing Dingrun
• Chongqing Nanfang
• Diagnostica Stago
• Framar Hemologix Srl
• Guizhou Jinjiu Biotech
• Haemonetics Corporation
• HemaCore LLC
• Instrumentation Laboratory（Werfen）
• Lepu Medical Technology
• Medcaptain Medical Technology
• Medirox AB
• Render Biotech Co., Ltd.
• Sienco, Inc.
• SYCOmed e.K.
• Ud-Bio
• WerfenLife
• WITEYE

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、人為的な売上原価の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

Global Industry Analystsは、世界の主要なチーフ・エコノミスト（1万4,949人）、シンクタンク（62団体）、貿易・産業団体（171団体）の専門家の意見に熱心に従いながら、エコシステムへの影響を評価し、新たな市場の現実に対処しています。あらゆる主要国の専門家やエコノミストが、関税とそれが自国に与える影響についての意見を追跡調査しています。

Global Industry Analystsは、この混乱が今後2-3ヶ月で収束し、新しい世界秩序がより明確に確立されると予想しています。Global Industry Analystsは、これらの開発をリアルタイムで追跡しています。

2025年4月：交渉フェーズ

4月のリリースでは、世界市場全体に対する関税の影響を取り上げ、地域別の市場調整について紹介します。当社の予測は、過去のデータと進化する市場影響要因に基づいています。

2025年7月：最終関税リセット

お客様には、各国間で最終リセットが発表された後の7月にも無料アップデートをお届けします。最終アップデート版には、明確に定義された関税影響分析が組み込まれています。

相互および二国間貿易と関税の影響分析：

アメリカ <>中国<>メキシコ <>カナダ <>EU <>日本<>インド <>その他176カ国

業界をリードするエコノミスト：Global Industry Analystsの知識ベースは、国家、シンクタンク、貿易・産業団体、大企業、そして世界の計量経済状況におけるこの前例のないパラダイムシフトの影響を共有する領域の専門家など、最も影響力のあるチーフエコノミストの厳選されたグループを含む1万4,949人のエコノミストを追跡しています。我々の16,491以上のレポートのほとんどは、マイルストーンに基づくこの2段階のリリーススケジュールを取り入れています。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

• 市場概要
• 主要企業
• 市場動向と促進要因
• 世界市場の見通し

第3章 市場分析

• 米国
• カナダ
• 日本
• 中国
• 欧州
• フランス
• ドイツ
• イタリア
• 英国
• スペイン
• ロシア
• その他欧州
• アジア太平洋
• オーストラリア
• インド
• 韓国
• その他アジア太平洋地域
• ラテンアメリカ
• アルゼンチン
• ブラジル
• メキシコ
• その他ラテンアメリカ
• 中東
• イラン
• イスラエル
• サウジアラビア
• アラブ首長国連邦
• その他中東
• アフリカ

第4章 競合

Global Thromboelastography Market to Reach US$933.1 Million by 2030

The global market for Thromboelastography estimated at US$672.1 Million in the year 2024, is expected to reach US$933.1 Million by 2030, growing at a CAGR of 5.6% over the analysis period 2024-2030. Standard Thromboelastography, one of the segments analyzed in the report, is expected to record a 7.3% CAGR and reach US$282.4 Million by the end of the analysis period. Growth in the Rapid TEG segment is estimated at 4.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$183.1 Million While China is Forecast to Grow at 9.2% CAGR

The Thromboelastography market in the U.S. is estimated at US$183.1 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$191.0 Million by the year 2030 trailing a CAGR of 9.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.6% and 5.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.7% CAGR.

Global "Thromboelastography" Market - Key Trends & Drivers Summarized

How Is Thromboelastography Redefining Hemostasis Testing in Critical Care?

Thromboelastography (TEG) is revolutionizing how clinicians assess hemostasis, moving beyond traditional coagulation assays by providing a dynamic, real-time evaluation of the entire clotting process. Unlike conventional lab tests such as PT, aPTT, or INR, which assess isolated points of the coagulation cascade, TEG offers a comprehensive view of clot formation, stabilization, and dissolution. This real-time assessment is especially valuable in trauma, cardiac surgery, liver transplantation, and intensive care settings, where rapid and accurate decisions about blood product administration can be life-saving. By tracking the viscoelastic properties of blood as it clots, TEG enables clinicians to pinpoint whether bleeding is due to platelet dysfunction, fibrinogen deficiency, or hyperfibrinolysis. The result is a personalized transfusion strategy that reduces unnecessary use of platelets, plasma, and cryoprecipitate, while improving patient outcomes. Increasing awareness of the risks of transfusion-related complications-such as TRALI and immunomodulation-is pushing hospitals to adopt more precise, targeted coagulation monitoring, and TEG systems are emerging as the go-to technology in this shift toward patient-specific hemostatic therapy.

Can Thromboelastography Become the New Standard in Surgical and Emergency Medicine?

The clinical versatility of thromboelastography is positioning it as a new standard of care in surgical and emergency medicine environments where bleeding complications are common and time-critical decisions are essential. In cardiac and liver surgeries, where coagulopathies are often complex and multi-factorial, TEG provides the granularity needed to distinguish between consumptive and dilutional coagulopathy, enabling precise intervention. Its utility in managing anticoagulated patients-whether on warfarin, DOACs, or heparin-makes it a valuable tool in both preoperative screening and intraoperative monitoring. Emergency departments are also turning to TEG in the management of trauma patients, where massive transfusion protocols can be optimized based on TEG-guided insights, reducing both morbidity and mortality. Obstetric centers are using TEG to assess bleeding risk in cases of postpartum hemorrhage, especially in preeclampsia and HELLP syndrome. Meanwhile, intensive care units (ICUs) are incorporating TEG for ongoing coagulation assessment in patients with sepsis, disseminated intravascular coagulation (DIC), or COVID-19-associated coagulopathy. The widespread applicability across medical disciplines and the demand for faster, data-driven decisions are driving a shift toward real-time coagulation diagnostics powered by TEG.

What Technological Enhancements Are Expanding the Capabilities of Thromboelastography?

Recent advancements in thromboelastography technology are making the systems more user-friendly, accurate, and adaptable to various clinical settings. Modern TEG analyzers feature automated sample handling, touch-screen interfaces, and integrated quality controls, reducing technician error and enabling consistent results. Portable and point-of-care (POC) TEG systems are expanding access to real-time coagulation monitoring beyond tertiary hospitals into smaller surgical centers, ambulances, and field hospitals. Software upgrades now allow for advanced analytics, cloud-based data sharing, and integration into electronic health records (EHRs), ensuring that results can be interpreted quickly and used effectively in multidisciplinary care. Some systems offer cartridge-based testing, eliminating the need for manual pipetting and enhancing biosafety during infectious disease outbreaks. Manufacturers are also exploring multiplexed assays and biomarker integration to improve diagnostic specificity and guide anticoagulant reversal strategies. Coupled with increased clinical training and algorithm-based decision support tools, these enhancements are reducing the learning curve and helping clinicians incorporate TEG insights into real-time therapeutic decisions, thereby expanding its utility across increasingly diverse healthcare environments.

The Growth in the Thromboelastography Market Is Driven by Several Factors…

The rising adoption of thromboelastography is primarily driven by its growing clinical relevance in high-risk surgical specialties, trauma care, and critical illness management. The increasing global burden of cardiovascular disease, liver disorders, and trauma cases-particularly in emerging economies-is necessitating more precise tools for hemostasis assessment and transfusion management. Additionally, as surgical volumes rise and minimally invasive procedures become more complex, the need for accurate intraoperative coagulation monitoring is intensifying. Hospitals are under pressure to reduce blood product usage both for cost containment and to avoid transfusion-related complications, pushing demand for precision-guided transfusion strategies like those enabled by TEG. In parallel, the rising prevalence of anticoagulant therapy and complex coagulopathies in aging populations is creating a need for technologies that can accurately evaluate clotting status in real time. Point-of-care testing trends and the decentralization of diagnostic services are also expanding TEG adoption beyond large hospitals to ambulatory surgical centers and emergency response units. Technological advancements-such as automation, portability, and EHR integration-are enhancing usability and reducing operational barriers, while regulatory approvals and clinical guideline endorsements are reinforcing TEG’s value in modern clinical workflows. These converging dynamics across technology, healthcare delivery, and patient demographics are propelling the rapid growth of the global thromboelastography market.

SCOPE OF STUDY:

The report analyzes the Thromboelastography market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Standard, Rapid TEG, Native TEG, Heparinase, Functional Fibrinogen, Platelet Mapping); Application (Cardiopulmonary Bypass, Liver Surgery, Trauma Surgery, Obstetrics); End-User (Hospitals, Blood Banks, Academic Institutes, Other End-Users)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

• 5-Diagnostics GmbH
• Bio-Zircon
• Biomart
• Chongqing Dingrun
• Chongqing Nanfang
• Diagnostica Stago
• Framar Hemologix Srl
• Guizhou Jinjiu Biotech
• Haemonetics Corporation
• HemaCore LLC
• Instrumentation Laboratory (Werfen)
• Lepu Medical Technology
• Medcaptain Medical Technology
• Medirox AB
• Render Biotech Co., Ltd.
• Sienco, Inc.
• SYCOmed e.K.
• Ud-Bio
• WerfenLife
• WITEYE

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA <> CHINA <> MEXICO <> CANADA <> EU <> JAPAN <> INDIA <> 176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

COMPLIMENTARY PREVIEW

Contact your sales agent to request an online 300+ page complimentary preview of this research project. Our preview will present full stack sources, and validated domain expert data transcripts. Deep dive into our interactive data-driven online platform.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Tariff Impact on Global Supply Chain Patterns
  • Thromboelastography - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Increased Surgical Procedures Drive Demand for Real-Time Hemostasis Testing
  • Rise in Trauma Cases and Critical Care Settings Strengthens Product Utilization
  • Rapid Adoption in Cardiovascular Surgery Expands Market Footprint
  • Personalized Medicine Initiatives Propel Growth of Point-of-Care Coagulation Analysis
  • Shift Toward Comprehensive Coagulation Profiling Drives Technological Innovation
  • Growing Use in Postpartum Hemorrhage and Liver Transplant Cases Broadens Applications
  • Clinical Evidence Supporting Improved Outcomes Spurs Adoption
  • Integration with Hospital EMR Systems Enhances Workflow Efficiency
  • Expanding Role in Anticoagulant Monitoring Increases Device Penetration
  • Training and Awareness Initiatives Drive Usage in Low-Penetration Markets
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Thromboelastography Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Thromboelastography by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Thromboelastography by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for Thromboelastography by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Standard by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Standard by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for Standard by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Rapid TEG by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Rapid TEG by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for Rapid TEG by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Native TEG by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Native TEG by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for Native TEG by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Heparinase by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Heparinase by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 16: World 15-Year Perspective for Heparinase by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Functional Fibrinogen by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Functional Fibrinogen by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 19: World 15-Year Perspective for Functional Fibrinogen by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Platelet Mapping by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Platelet Mapping by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 22: World 15-Year Perspective for Platelet Mapping by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Obstetrics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Obstetrics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 25: World 15-Year Perspective for Obstetrics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Cardiopulmonary Bypass by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Cardiopulmonary Bypass by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 28: World 15-Year Perspective for Cardiopulmonary Bypass by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Liver Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Liver Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 31: World 15-Year Perspective for Liver Surgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Trauma Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Trauma Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 34: World 15-Year Perspective for Trauma Surgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 37: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 38: World Recent Past, Current & Future Analysis for Blood Banks by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 39: World Historic Review for Blood Banks by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 40: World 15-Year Perspective for Blood Banks by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 41: World Recent Past, Current & Future Analysis for Academic Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 42: World Historic Review for Academic Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 43: World 15-Year Perspective for Academic Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 44: World Recent Past, Current & Future Analysis for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 45: World Historic Review for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 46: World 15-Year Perspective for Other End-Users by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Thromboelastography Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 47: USA Recent Past, Current & Future Analysis for Thromboelastography by Type - Standard, Rapid TEG, Native TEG, Heparinase, Functional Fibrinogen and Platelet Mapping - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 48: USA Historic Review for Thromboelastography by Type - Standard, Rapid TEG, Native TEG, Heparinase, Functional Fibrinogen and Platelet Mapping Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 49: USA 15-Year Perspective for Thromboelastography by Type - Percentage Breakdown of Value Sales for Standard, Rapid TEG, Native TEG, Heparinase, Functional Fibrinogen and Platelet Mapping for the Years 2015, 2025 & 2030
  • TABLE 50: USA Recent Past, Current & Future Analysis for Thromboelastography by Application - Obstetrics, Cardiopulmonary Bypass, Liver Surgery and Trauma Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 51: USA Historic Review for Thromboelastography by Application - Obstetrics, Cardiopulmonary Bypass, Liver Surgery and Trauma Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 52: USA 15-Year Perspective for Thromboelastography by Application - Percentage Breakdown of Value Sales for Obstetrics, Cardiopulmonary Bypass, Liver Surgery and Trauma Surgery for the Years 2015, 2025 & 2030
  • TABLE 53: USA Recent Past, Current & Future Analysis for Thromboelastography by End-user - Hospitals, Blood Banks, Academic Institutes and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 54: USA Historic Review for Thromboelastography by End-user - Hospitals, Blood Banks, Academic Institutes and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 55: USA 15-Year Perspective for Thromboelastography by End-user - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Academic Institutes and Other End-Users for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 56: Canada Recent Past, Current & Future Analysis for Thromboelastography by Type - Standard, Rapid TEG, Native TEG, Heparinase, Functional Fibrinogen and Platelet Mapping - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Canada Historic Review for Thromboelastography by Type - Standard, Rapid TEG, Native TEG, Heparinase, Functional Fibrinogen and Platelet Mapping Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 58: Canada 15-Year Perspective for Thromboelastography by Type - Percentage Breakdown of Value Sales for Standard, Rapid TEG, Native TEG, Heparinase, Functional Fibrinogen and Platelet Mapping for the Years 2015, 2025 & 2030
  • TABLE 59: Canada Recent Past, Current & Future Analysis for Thromboelastography by Application - Obstetrics, Cardiopulmonary Bypass, Liver Surgery and Trauma Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 60: Canada Historic Review for Thromboelastography by Application - Obstetrics, Cardiopulmonary Bypass, Liver Surgery and Trauma Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 61: Canada 15-Year Perspective for Thromboelastography by Application - Percentage Breakdown of Value Sales for Obstetrics, Cardiopulmonary Bypass, Liver Surgery and Trauma Surgery for the Years 2015, 2025 & 2030
  • TABLE 62: Canada Recent Past, Current & Future Analysis for Thromboelastography by End-user - Hospitals, Blood Banks, Academic Institutes and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 63: Canada Historic Review for Thromboelastography by End-user - Hospitals, Blood Banks, Academic Institutes and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 64: Canada 15-Year Perspective for Thromboelastography by End-user - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Academic Institutes and Other End-Users for the Years 2015, 2025 & 2030
• JAPAN
  • Thromboelastography Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 65: Japan Recent Past, Current & Future Analysis for Thromboelastography by Type - Standard, Rapid TEG, Native TEG, Heparinase, Functional Fibrinogen and Platelet Mapping - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 66: Japan Historic Review for Thromboelastography by Type - Standard, Rapid TEG, Native TEG, Heparinase, Functional Fibrinogen and Platelet Mapping Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 67: Japan 15-Year Perspective for Thromboelastography by Type - Percentage Breakdown of Value Sales for Standard, Rapid TEG, Native TEG, Heparinase, Functional Fibrinogen and Platelet Mapping for the Years 2015, 2025 & 2030
  • TABLE 68: Japan Recent Past, Current & Future Analysis for Thromboelastography by Application - Obstetrics, Cardiopulmonary Bypass, Liver Surgery and Trauma Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 69: Japan Historic Review for Thromboelastography by Application - Obstetrics, Cardiopulmonary Bypass, Liver Surgery and Trauma Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 70: Japan 15-Year Perspective for Thromboelastography by Application - Percentage Breakdown of Value Sales for Obstetrics, Cardiopulmonary Bypass, Liver Surgery and Trauma Surgery for the Years 2015, 2025 & 2030
  • TABLE 71: Japan Recent Past, Current & Future Analysis for Thromboelastography by End-user - Hospitals, Blood Banks, Academic Institutes and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 72: Japan Historic Review for Thromboelastography by End-user - Hospitals, Blood Banks, Academic Institutes and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 73: Japan 15-Year Perspective for Thromboelastography by End-user - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Academic Institutes and Other End-Users for the Years 2015, 2025 & 2030
• CHINA
  • Thromboelastography Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 74: China Recent Past, Current & Future Analysis for Thromboelastography by Type - Standard, Rapid TEG, Native TEG, Heparinase, Functional Fibrinogen and Platelet Mapping - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 75: China Historic Review for Thromboelastography by Type - Standard, Rapid TEG, Native TEG, Heparinase, Functional Fibrinogen and Platelet Mapping Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 76: China 15-Year Perspective for Thromboelastography by Type - Percentage Breakdown of Value Sales for Standard, Rapid TEG, Native TEG, Heparinase, Functional Fibrinogen and Platelet Mapping for the Years 2015, 2025 & 2030
  • TABLE 77: China Recent Past, Current & Future Analysis for Thromboelastography by Application - Obstetrics, Cardiopulmonary Bypass, Liver Surgery and Trauma Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 78: China Historic Review for Thromboelastography by Application - Obstetrics, Cardiopulmonary Bypass, Liver Surgery and Trauma Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 79: China 15-Year Perspective for Thromboelastography by Application - Percentage Breakdown of Value Sales for Obstetrics, Cardiopulmonary Bypass, Liver Surgery and Trauma Surgery for the Years 2015, 2025 & 2030
  • TABLE 80: China Recent Past, Current & Future Analysis for Thromboelastography by End-user - Hospitals, Blood Banks, Academic Institutes and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 81: China Historic Review for Thromboelastography by End-user - Hospitals, Blood Banks, Academic Institutes and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 82: China 15-Year Perspective for Thromboelastography by End-user - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Academic Institutes and Other End-Users for the Years 2015, 2025 & 2030
• EUROPE
  • Thromboelastography Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 83: Europe Recent Past, Current & Future Analysis for Thromboelastography by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 84: Europe Historic Review for Thromboelastography by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 85: Europe 15-Year Perspective for Thromboelastography by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 86: Europe Recent Past, Current & Future Analysis for Thromboelastography by Type - Standard, Rapid TEG, Native TEG, Heparinase, Functional Fibrinogen and Platelet Mapping - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 87: Europe Historic Review for Thromboelastography by Type - Standard, Rapid TEG, Native TEG, Heparinase, Functional Fibrinogen and Platelet Mapping Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 88: Europe 15-Year Perspective for Thromboelastography by Type - Percentage Breakdown of Value Sales for Standard, Rapid TEG, Native TEG, Heparinase, Functional Fibrinogen and Platelet Mapping for the Years 2015, 2025 & 2030
  • TABLE 89: Europe Recent Past, Current & Future Analysis for Thromboelastography by Application - Obstetrics, Cardiopulmonary Bypass, Liver Surgery and Trauma Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 90: Europe Historic Review for Thromboelastography by Application - Obstetrics, Cardiopulmonary Bypass, Liver Surgery and Trauma Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 91: Europe 15-Year Perspective for Thromboelastography by Application - Percentage Breakdown of Value Sales for Obstetrics, Cardiopulmonary Bypass, Liver Surgery and Trauma Surgery for the Years 2015, 2025 & 2030
  • TABLE 92: Europe Recent Past, Current & Future Analysis for Thromboelastography by End-user - Hospitals, Blood Banks, Academic Institutes and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 93: Europe Historic Review for Thromboelastography by End-user - Hospitals, Blood Banks, Academic Institutes and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 94: Europe 15-Year Perspective for Thromboelastography by End-user - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Academic Institutes and Other End-Users for the Years 2015, 2025 & 2030
• FRANCE
  • Thromboelastography Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 95: France Recent Past, Current & Future Analysis for Thromboelastography by Type - Standard, Rapid TEG, Native TEG, Heparinase, Functional Fibrinogen and Platelet Mapping - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 96: France Historic Review for Thromboelastography by Type - Standard, Rapid TEG, Native TEG, Heparinase, Functional Fibrinogen and Platelet Mapping Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 97: France 15-Year Perspective for Thromboelastography by Type - Percentage Breakdown of Value Sales for Standard, Rapid TEG, Native TEG, Heparinase, Functional Fibrinogen and Platelet Mapping for the Years 2015, 2025 & 2030
  • TABLE 98: France Recent Past, Current & Future Analysis for Thromboelastography by Application - Obstetrics, Cardiopulmonary Bypass, Liver Surgery and Trauma Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 99: France Historic Review for Thromboelastography by Application - Obstetrics, Cardiopulmonary Bypass, Liver Surgery and Trauma Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 100: France 15-Year Perspective for Thromboelastography by Application - Percentage Breakdown of Value Sales for Obstetrics, Cardiopulmonary Bypass, Liver Surgery and Trauma Surgery for the Years 2015, 2025 & 2030
  • TABLE 101: France Recent Past, Current & Future Analysis for Thromboelastography by End-user - Hospitals, Blood Banks, Academic Institutes and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 102: France Historic Review for Thromboelastography by End-user - Hospitals, Blood Banks, Academic Institutes and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 103: France 15-Year Perspective for Thromboelastography by End-user - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Academic Institutes and Other End-Users for the Years 2015, 2025 & 2030
• GERMANY
  • Thromboelastography Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 104: Germany Recent Past, Current & Future Analysis for Thromboelastography by Type - Standard, Rapid TEG, Native TEG, Heparinase, Functional Fibrinogen and Platelet Mapping - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Germany Historic Review for Thromboelastography by Type - Standard, Rapid TEG, Native TEG, Heparinase, Functional Fibrinogen and Platelet Mapping Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 106: Germany 15-Year Perspective for Thromboelastography by Type - Percentage Breakdown of Value Sales for Standard, Rapid TEG, Native TEG, Heparinase, Functional Fibrinogen and Platelet Mapping for the Years 2015, 2025 & 2030
  • TABLE 107: Germany Recent Past, Current & Future Analysis for Thromboelastography by Application - Obstetrics, Cardiopulmonary Bypass, Liver Surgery and Trauma Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 108: Germany Historic Review for Thromboelastography by Application - Obstetrics, Cardiopulmonary Bypass, Liver Surgery and Trauma Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 109: Germany 15-Year Perspective for Thromboelastography by Application - Percentage Breakdown of Value Sales for Obstetrics, Cardiopulmonary Bypass, Liver Surgery and Trauma Surgery for the Years 2015, 2025 & 2030
  • TABLE 110: Germany Recent Past, Current & Future Analysis for Thromboelastography by End-user - Hospitals, Blood Banks, Academic Institutes and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 111: Germany Historic Review for Thromboelastography by End-user - Hospitals, Blood Banks, Academic Institutes and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 112: Germany 15-Year Perspective for Thromboelastography by End-user - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Academic Institutes and Other End-Users for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 113: Italy Recent Past, Current & Future Analysis for Thromboelastography by Type - Standard, Rapid TEG, Native TEG, Heparinase, Functional Fibrinogen and Platelet Mapping - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 114: Italy Historic Review for Thromboelastography by Type - Standard, Rapid TEG, Native TEG, Heparinase, Functional Fibrinogen and Platelet Mapping Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 115: Italy 15-Year Perspective for Thromboelastography by Type - Percentage Breakdown of Value Sales for Standard, Rapid TEG, Native TEG, Heparinase, Functional Fibrinogen and Platelet Mapping for the Years 2015, 2025 & 2030
  • TABLE 116: Italy Recent Past, Current & Future Analysis for Thromboelastography by Application - Obstetrics, Cardiopulmonary Bypass, Liver Surgery and Trauma Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 117: Italy Historic Review for Thromboelastography by Application - Obstetrics, Cardiopulmonary Bypass, Liver Surgery and Trauma Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 118: Italy 15-Year Perspective for Thromboelastography by Application - Percentage Breakdown of Value Sales for Obstetrics, Cardiopulmonary Bypass, Liver Surgery and Trauma Surgery for the Years 2015, 2025 & 2030
  • TABLE 119: Italy Recent Past, Current & Future Analysis for Thromboelastography by End-user - Hospitals, Blood Banks, Academic Institutes and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 120: Italy Historic Review for Thromboelastography by End-user - Hospitals, Blood Banks, Academic Institutes and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 121: Italy 15-Year Perspective for Thromboelastography by End-user - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Academic Institutes and Other End-Users for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Thromboelastography Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 122: UK Recent Past, Current & Future Analysis for Thromboelastography by Type - Standard, Rapid TEG, Native TEG, Heparinase, Functional Fibrinogen and Platelet Mapping - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 123: UK Historic Review for Thromboelastography by Type - Standard, Rapid TEG, Native TEG, Heparinase, Functional Fibrinogen and Platelet Mapping Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 124: UK 15-Year Perspective for Thromboelastography by Type - Percentage Breakdown of Value Sales for Standard, Rapid TEG, Native TEG, Heparinase, Functional Fibrinogen and Platelet Mapping for the Years 2015, 2025 & 2030
  • TABLE 125: UK Recent Past, Current & Future Analysis for Thromboelastography by Application - Obstetrics, Cardiopulmonary Bypass, Liver Surgery and Trauma Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 126: UK Historic Review for Thromboelastography by Application - Obstetrics, Cardiopulmonary Bypass, Liver Surgery and Trauma Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 127: UK 15-Year Perspective for Thromboelastography by Application - Percentage Breakdown of Value Sales for Obstetrics, Cardiopulmonary Bypass, Liver Surgery and Trauma Surgery for the Years 2015, 2025 & 2030
  • TABLE 128: UK Recent Past, Current & Future Analysis for Thromboelastography by End-user - Hospitals, Blood Banks, Academic Institutes and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 129: UK Historic Review for Thromboelastography by End-user - Hospitals, Blood Banks, Academic Institutes and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 130: UK 15-Year Perspective for Thromboelastography by End-user - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Academic Institutes and Other End-Users for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 131: Spain Recent Past, Current & Future Analysis for Thromboelastography by Type - Standard, Rapid TEG, Native TEG, Heparinase, Functional Fibrinogen and Platelet Mapping - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Spain Historic Review for Thromboelastography by Type - Standard, Rapid TEG, Native TEG, Heparinase, Functional Fibrinogen and Platelet Mapping Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 133: Spain 15-Year Perspective for Thromboelastography by Type - Percentage Breakdown of Value Sales for Standard, Rapid TEG, Native TEG, Heparinase, Functional Fibrinogen and Platelet Mapping for the Years 2015, 2025 & 2030
  • TABLE 134: Spain Recent Past, Current & Future Analysis for Thromboelastography by Application - Obstetrics, Cardiopulmonary Bypass, Liver Surgery and Trauma Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Spain Historic Review for Thromboelastography by Application - Obstetrics, Cardiopulmonary Bypass, Liver Surgery and Trauma Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 136: Spain 15-Year Perspective for Thromboelastography by Application - Percentage Breakdown of Value Sales for Obstetrics, Cardiopulmonary Bypass, Liver Surgery and Trauma Surgery for the Years 2015, 2025 & 2030
  • TABLE 137: Spain Recent Past, Current & Future Analysis for Thromboelastography by End-user - Hospitals, Blood Banks, Academic Institutes and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Spain Historic Review for Thromboelastography by End-user - Hospitals, Blood Banks, Academic Institutes and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 139: Spain 15-Year Perspective for Thromboelastography by End-user - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Academic Institutes and Other End-Users for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 140: Russia Recent Past, Current & Future Analysis for Thromboelastography by Type - Standard, Rapid TEG, Native TEG, Heparinase, Functional Fibrinogen and Platelet Mapping - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Russia Historic Review for Thromboelastography by Type - Standard, Rapid TEG, Native TEG, Heparinase, Functional Fibrinogen and Platelet Mapping Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 142: Russia 15-Year Perspective for Thromboelastography by Type - Percentage Breakdown of Value Sales for Standard, Rapid TEG, Native TEG, Heparinase, Functional Fibrinogen and Platelet Mapping for the Years 2015, 2025 & 2030
  • TABLE 143: Russia Recent Past, Current & Future Analysis for Thromboelastography by Application - Obstetrics, Cardiopulmonary Bypass, Liver Surgery and Trauma Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Russia Historic Review for Thromboelastography by Application - Obstetrics, Cardiopulmonary Bypass, Liver Surgery and Trauma Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 145: Russia 15-Year Perspective for Thromboelastography by Application - Percentage Breakdown of Value Sales for Obstetrics, Cardiopulmonary Bypass, Liver Surgery and Trauma Surgery for the Years 2015, 2025 & 2030
  • TABLE 146: Russia Recent Past, Current & Future Analysis for Thromboelastography by End-user - Hospitals, Blood Banks, Academic Institutes and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Russia Historic Review for Thromboelastography by End-user - Hospitals, Blood Banks, Academic Institutes and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 148: Russia 15-Year Perspective for Thromboelastography by End-user - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Academic Institutes and Other End-Users for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 149: Rest of Europe Recent Past, Current & Future Analysis for Thromboelastography by Type - Standard, Rapid TEG, Native TEG, Heparinase, Functional Fibrinogen and Platelet Mapping - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Rest of Europe Historic Review for Thromboelastography by Type - Standard, Rapid TEG, Native TEG, Heparinase, Functional Fibrinogen and Platelet Mapping Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 151: Rest of Europe 15-Year Perspective for Thromboelastography by Type - Percentage Breakdown of Value Sales for Standard, Rapid TEG, Native TEG, Heparinase, Functional Fibrinogen and Platelet Mapping for the Years 2015, 2025 & 2030
  • TABLE 152: Rest of Europe Recent Past, Current & Future Analysis for Thromboelastography by Application - Obstetrics, Cardiopulmonary Bypass, Liver Surgery and Trauma Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Rest of Europe Historic Review for Thromboelastography by Application - Obstetrics, Cardiopulmonary Bypass, Liver Surgery and Trauma Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 154: Rest of Europe 15-Year Perspective for Thromboelastography by Application - Percentage Breakdown of Value Sales for Obstetrics, Cardiopulmonary Bypass, Liver Surgery and Trauma Surgery for the Years 2015, 2025 & 2030
  • TABLE 155: Rest of Europe Recent Past, Current & Future Analysis for Thromboelastography by End-user - Hospitals, Blood Banks, Academic Institutes and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Rest of Europe Historic Review for Thromboelastography by End-user - Hospitals, Blood Banks, Academic Institutes and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 157: Rest of Europe 15-Year Perspective for Thromboelastography by End-user - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Academic Institutes and Other End-Users for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Thromboelastography Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Thromboelastography by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 159: Asia-Pacific Historic Review for Thromboelastography by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 160: Asia-Pacific 15-Year Perspective for Thromboelastography by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 161: Asia-Pacific Recent Past, Current & Future Analysis for Thromboelastography by Type - Standard, Rapid TEG, Native TEG, Heparinase, Functional Fibrinogen and Platelet Mapping - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Asia-Pacific Historic Review for Thromboelastography by Type - Standard, Rapid TEG, Native TEG, Heparinase, Functional Fibrinogen and Platelet Mapping Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 163: Asia-Pacific 15-Year Perspective for Thromboelastography by Type - Percentage Breakdown of Value Sales for Standard, Rapid TEG, Native TEG, Heparinase, Functional Fibrinogen and Platelet Mapping for the Years 2015, 2025 & 2030
  • TABLE 164: Asia-Pacific Recent Past, Current & Future Analysis for Thromboelastography by Application - Obstetrics, Cardiopulmonary Bypass, Liver Surgery and Trauma Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Asia-Pacific Historic Review for Thromboelastography by Application - Obstetrics, Cardiopulmonary Bypass, Liver Surgery and Trauma Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 166: Asia-Pacific 15-Year Perspective for Thromboelastography by Application - Percentage Breakdown of Value Sales for Obstetrics, Cardiopulmonary Bypass, Liver Surgery and Trauma Surgery for the Years 2015, 2025 & 2030
  • TABLE 167: Asia-Pacific Recent Past, Current & Future Analysis for Thromboelastography by End-user - Hospitals, Blood Banks, Academic Institutes and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Asia-Pacific Historic Review for Thromboelastography by End-user - Hospitals, Blood Banks, Academic Institutes and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 169: Asia-Pacific 15-Year Perspective for Thromboelastography by End-user - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Academic Institutes and Other End-Users for the Years 2015, 2025 & 2030
• AUSTRALIA
  • Thromboelastography Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 170: Australia Recent Past, Current & Future Analysis for Thromboelastography by Type - Standard, Rapid TEG, Native TEG, Heparinase, Functional Fibrinogen and Platelet Mapping - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 171: Australia Historic Review for Thromboelastography by Type - Standard, Rapid TEG, Native TEG, Heparinase, Functional Fibrinogen and Platelet Mapping Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 172: Australia 15-Year Perspective for Thromboelastography by Type - Percentage Breakdown of Value Sales for Standard, Rapid TEG, Native TEG, Heparinase, Functional Fibrinogen and Platelet Mapping for the Years 2015, 2025 & 2030
  • TABLE 173: Australia Recent Past, Current & Future Analysis for Thromboelastography by Application - Obstetrics, Cardiopulmonary Bypass, Liver Surgery and Trauma Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 174: Australia Historic Review for Thromboelastography by Application - Obstetrics, Cardiopulmonary Bypass, Liver Surgery and Trauma Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 175: Australia 15-Year Perspective for Thromboelastography by Application - Percentage Breakdown of Value Sales for Obstetrics, Cardiopulmonary Bypass, Liver Surgery and Trauma Surgery for the Years 2015, 2025 & 2030
  • TABLE 176: Australia Recent Past, Current & Future Analysis for Thromboelastography by End-user - Hospitals, Blood Banks, Academic Institutes and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 177: Australia Historic Review for Thromboelastography by End-user - Hospitals, Blood Banks, Academic Institutes and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 178: Australia 15-Year Perspective for Thromboelastography by End-user - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Academic Institutes and Other End-Users for the Years 2015, 2025 & 2030
• INDIA
  • Thromboelastography Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 179: India Recent Past, Current & Future Analysis for Thromboelastography by Type - Standard, Rapid TEG, Native TEG, Heparinase, Functional Fibrinogen and Platelet Mapping - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 180: India Historic Review for Thromboelastography by Type - Standard, Rapid TEG, Native TEG, Heparinase, Functional Fibrinogen and Platelet Mapping Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 181: India 15-Year Perspective for Thromboelastography by Type - Percentage Breakdown of Value Sales for Standard, Rapid TEG, Native TEG, Heparinase, Functional Fibrinogen and Platelet Mapping for the Years 2015, 2025 & 2030
  • TABLE 182: India Recent Past, Current & Future Analysis for Thromboelastography by Application - Obstetrics, Cardiopulmonary Bypass, Liver Surgery and Trauma Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 183: India Historic Review for Thromboelastography by Application - Obstetrics, Cardiopulmonary Bypass, Liver Surgery and Trauma Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 184: India 15-Year Perspective for Thromboelastography by Application - Percentage Breakdown of Value Sales for Obstetrics, Cardiopulmonary Bypass, Liver Surgery and Trauma Surgery for the Years 2015, 2025 & 2030
  • TABLE 185: India Recent Past, Current & Future Analysis for Thromboelastography by End-user - Hospitals, Blood Banks, Academic Institutes and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 186: India Historic Review for Thromboelastography by End-user - Hospitals, Blood Banks, Academic Institutes and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 187: India 15-Year Perspective for Thromboelastography by End-user - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Academic Institutes and Other End-Users for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 188: South Korea Recent Past, Current & Future Analysis for Thromboelastography by Type - Standard, Rapid TEG, Native TEG, Heparinase, Functional Fibrinogen and Platelet Mapping - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 189: South Korea Historic Review for Thromboelastography by Type - Standard, Rapid TEG, Native TEG, Heparinase, Functional Fibrinogen and Platelet Mapping Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 190: South Korea 15-Year Perspective for Thromboelastography by Type - Percentage Breakdown of Value Sales for Standard, Rapid TEG, Native TEG, Heparinase, Functional Fibrinogen and Platelet Mapping for the Years 2015, 2025 & 2030
  • TABLE 191: South Korea Recent Past, Current & Future Analysis for Thromboelastography by Application - Obstetrics, Cardiopulmonary Bypass, Liver Surgery and Trauma Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 192: South Korea Historic Review for Thromboelastography by Application - Obstetrics, Cardiopulmonary Bypass, Liver Surgery and Trauma Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 193: South Korea 15-Year Perspective for Thromboelastography by Application - Percentage Breakdown of Value Sales for Obstetrics, Cardiopulmonary Bypass, Liver Surgery and Trauma Surgery for the Years 2015, 2025 & 2030
  • TABLE 194: South Korea Recent Past, Current & Future Analysis for Thromboelastography by End-user - Hospitals, Blood Banks, Academic Institutes and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 195: South Korea Historic Review for Thromboelastography by End-user - Hospitals, Blood Banks, Academic Institutes and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 196: South Korea 15-Year Perspective for Thromboelastography by End-user - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Academic Institutes and Other End-Users for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 197: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Thromboelastography by Type - Standard, Rapid TEG, Native TEG, Heparinase, Functional Fibrinogen and Platelet Mapping - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Rest of Asia-Pacific Historic Review for Thromboelastography by Type - Standard, Rapid TEG, Native TEG, Heparinase, Functional Fibrinogen and Platelet Mapping Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 199: Rest of Asia-Pacific 15-Year Perspective for Thromboelastography by Type - Percentage Breakdown of Value Sales for Standard, Rapid TEG, Native TEG, Heparinase, Functional Fibrinogen and Platelet Mapping for the Years 2015, 2025 & 2030
  • TABLE 200: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Thromboelastography by Application - Obstetrics, Cardiopulmonary Bypass, Liver Surgery and Trauma Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Rest of Asia-Pacific Historic Review for Thromboelastography by Application - Obstetrics, Cardiopulmonary Bypass, Liver Surgery and Trauma Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 202: Rest of Asia-Pacific 15-Year Perspective for Thromboelastography by Application - Percentage Breakdown of Value Sales for Obstetrics, Cardiopulmonary Bypass, Liver Surgery and Trauma Surgery for the Years 2015, 2025 & 2030
  • TABLE 203: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Thromboelastography by End-user - Hospitals, Blood Banks, Academic Institutes and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Rest of Asia-Pacific Historic Review for Thromboelastography by End-user - Hospitals, Blood Banks, Academic Institutes and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 205: Rest of Asia-Pacific 15-Year Perspective for Thromboelastography by End-user - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Academic Institutes and Other End-Users for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Thromboelastography Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 206: Latin America Recent Past, Current & Future Analysis for Thromboelastography by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 207: Latin America Historic Review for Thromboelastography by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 208: Latin America 15-Year Perspective for Thromboelastography by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 209: Latin America Recent Past, Current & Future Analysis for Thromboelastography by Type - Standard, Rapid TEG, Native TEG, Heparinase, Functional Fibrinogen and Platelet Mapping - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Latin America Historic Review for Thromboelastography by Type - Standard, Rapid TEG, Native TEG, Heparinase, Functional Fibrinogen and Platelet Mapping Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 211: Latin America 15-Year Perspective for Thromboelastography by Type - Percentage Breakdown of Value Sales for Standard, Rapid TEG, Native TEG, Heparinase, Functional Fibrinogen and Platelet Mapping for the Years 2015, 2025 & 2030
  • TABLE 212: Latin America Recent Past, Current & Future Analysis for Thromboelastography by Application - Obstetrics, Cardiopulmonary Bypass, Liver Surgery and Trauma Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Latin America Historic Review for Thromboelastography by Application - Obstetrics, Cardiopulmonary Bypass, Liver Surgery and Trauma Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 214: Latin America 15-Year Perspective for Thromboelastography by Application - Percentage Breakdown of Value Sales for Obstetrics, Cardiopulmonary Bypass, Liver Surgery and Trauma Surgery for the Years 2015, 2025 & 2030
  • TABLE 215: Latin America Recent Past, Current & Future Analysis for Thromboelastography by End-user - Hospitals, Blood Banks, Academic Institutes and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Latin America Historic Review for Thromboelastography by End-user - Hospitals, Blood Banks, Academic Institutes and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 217: Latin America 15-Year Perspective for Thromboelastography by End-user - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Academic Institutes and Other End-Users for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 218: Argentina Recent Past, Current & Future Analysis for Thromboelastography by Type - Standard, Rapid TEG, Native TEG, Heparinase, Functional Fibrinogen and Platelet Mapping - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Argentina Historic Review for Thromboelastography by Type - Standard, Rapid TEG, Native TEG, Heparinase, Functional Fibrinogen and Platelet Mapping Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 220: Argentina 15-Year Perspective for Thromboelastography by Type - Percentage Breakdown of Value Sales for Standard, Rapid TEG, Native TEG, Heparinase, Functional Fibrinogen and Platelet Mapping for the Years 2015, 2025 & 2030
  • TABLE 221: Argentina Recent Past, Current & Future Analysis for Thromboelastography by Application - Obstetrics, Cardiopulmonary Bypass, Liver Surgery and Trauma Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Argentina Historic Review for Thromboelastography by Application - Obstetrics, Cardiopulmonary Bypass, Liver Surgery and Trauma Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 223: Argentina 15-Year Perspective for Thromboelastography by Application - Percentage Breakdown of Value Sales for Obstetrics, Cardiopulmonary Bypass, Liver Surgery and Trauma Surgery for the Years 2015, 2025 & 2030
  • TABLE 224: Argentina Recent Past, Current & Future Analysis for Thromboelastography by End-user - Hospitals, Blood Banks, Academic Institutes and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Argentina Historic Review for Thromboelastography by End-user - Hospitals, Blood Banks, Academic Institutes and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 226: Argentina 15-Year Perspective for Thromboelastography by End-user - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Academic Institutes and Other End-Users for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 227: Brazil Recent Past, Current & Future Analysis for Thromboelastography by Type - Standard, Rapid TEG, Native TEG, Heparinase, Functional Fibrinogen and Platelet Mapping - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Brazil Historic Review for Thromboelastography by Type - Standard, Rapid TEG, Native TEG, Heparinase, Functional Fibrinogen and Platelet Mapping Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 229: Brazil 15-Year Perspective for Thromboelastography by Type - Percentage Breakdown of Value Sales for Standard, Rapid TEG, Native TEG, Heparinase, Functional Fibrinogen and Platelet Mapping for the Years 2015, 2025 & 2030
  • TABLE 230: Brazil Recent Past, Current & Future Analysis for Thromboelastography by Application - Obstetrics, Cardiopulmonary Bypass, Liver Surgery and Trauma Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Brazil Historic Review for Thromboelastography by Application - Obstetrics, Cardiopulmonary Bypass, Liver Surgery and Trauma Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 232: Brazil 15-Year Perspective for Thromboelastography by Application - Percentage Breakdown of Value Sales for Obstetrics, Cardiopulmonary Bypass, Liver Surgery and Trauma Surgery for the Years 2015, 2025 & 2030
  • TABLE 233: Brazil Recent Past, Current & Future Analysis for Thromboelastography by End-user - Hospitals, Blood Banks, Academic Institutes and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Brazil Historic Review for Thromboelastography by End-user - Hospitals, Blood Banks, Academic Institutes and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 235: Brazil 15-Year Perspective for Thromboelastography by End-user - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Academic Institutes and Other End-Users for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 236: Mexico Recent Past, Current & Future Analysis for Thromboelastography by Type - Standard, Rapid TEG, Native TEG, Heparinase, Functional Fibrinogen and Platelet Mapping - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Mexico Historic Review for Thromboelastography by Type - Standard, Rapid TEG, Native TEG, Heparinase, Functional Fibrinogen and Platelet Mapping Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 238: Mexico 15-Year Perspective for Thromboelastography by Type - Percentage Breakdown of Value Sales for Standard, Rapid TEG, Native TEG, Heparinase, Functional Fibrinogen and Platelet Mapping for the Years 2015, 2025 & 2030
  • TABLE 239: Mexico Recent Past, Current & Future Analysis for Thromboelastography by Application - Obstetrics, Cardiopulmonary Bypass, Liver Surgery and Trauma Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Mexico Historic Review for Thromboelastography by Application - Obstetrics, Cardiopulmonary Bypass, Liver Surgery and Trauma Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 241: Mexico 15-Year Perspective for Thromboelastography by Application - Percentage Breakdown of Value Sales for Obstetrics, Cardiopulmonary Bypass, Liver Surgery and Trauma Surgery for the Years 2015, 2025 & 2030
  • TABLE 242: Mexico Recent Past, Current & Future Analysis for Thromboelastography by End-user - Hospitals, Blood Banks, Academic Institutes and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Mexico Historic Review for Thromboelastography by End-user - Hospitals, Blood Banks, Academic Institutes and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 244: Mexico 15-Year Perspective for Thromboelastography by End-user - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Academic Institutes and Other End-Users for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 245: Rest of Latin America Recent Past, Current & Future Analysis for Thromboelastography by Type - Standard, Rapid TEG, Native TEG, Heparinase, Functional Fibrinogen and Platelet Mapping - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Rest of Latin America Historic Review for Thromboelastography by Type - Standard, Rapid TEG, Native TEG, Heparinase, Functional Fibrinogen and Platelet Mapping Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 247: Rest of Latin America 15-Year Perspective for Thromboelastography by Type - Percentage Breakdown of Value Sales for Standard, Rapid TEG, Native TEG, Heparinase, Functional Fibrinogen and Platelet Mapping for the Years 2015, 2025 & 2030
  • TABLE 248: Rest of Latin America Recent Past, Current & Future Analysis for Thromboelastography by Application - Obstetrics, Cardiopulmonary Bypass, Liver Surgery and Trauma Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Rest of Latin America Historic Review for Thromboelastography by Application - Obstetrics, Cardiopulmonary Bypass, Liver Surgery and Trauma Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 250: Rest of Latin America 15-Year Perspective for Thromboelastography by Application - Percentage Breakdown of Value Sales for Obstetrics, Cardiopulmonary Bypass, Liver Surgery and Trauma Surgery for the Years 2015, 2025 & 2030
  • TABLE 251: Rest of Latin America Recent Past, Current & Future Analysis for Thromboelastography by End-user - Hospitals, Blood Banks, Academic Institutes and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Rest of Latin America Historic Review for Thromboelastography by End-user - Hospitals, Blood Banks, Academic Institutes and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 253: Rest of Latin America 15-Year Perspective for Thromboelastography by End-user - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Academic Institutes and Other End-Users for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Thromboelastography Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 254: Middle East Recent Past, Current & Future Analysis for Thromboelastography by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 255: Middle East Historic Review for Thromboelastography by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 256: Middle East 15-Year Perspective for Thromboelastography by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 257: Middle East Recent Past, Current & Future Analysis for Thromboelastography by Type - Standard, Rapid TEG, Native TEG, Heparinase, Functional Fibrinogen and Platelet Mapping - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Middle East Historic Review for Thromboelastography by Type - Standard, Rapid TEG, Native TEG, Heparinase, Functional Fibrinogen and Platelet Mapping Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 259: Middle East 15-Year Perspective for Thromboelastography by Type - Percentage Breakdown of Value Sales for Standard, Rapid TEG, Native TEG, Heparinase, Functional Fibrinogen and Platelet Mapping for the Years 2015, 2025 & 2030
  • TABLE 260: Middle East Recent Past, Current & Future Analysis for Thromboelastography by Application - Obstetrics, Cardiopulmonary Bypass, Liver Surgery and Trauma Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Middle East Historic Review for Thromboelastography by Application - Obstetrics, Cardiopulmonary Bypass, Liver Surgery and Trauma Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 262: Middle East 15-Year Perspective for Thromboelastography by Application - Percentage Breakdown of Value Sales for Obstetrics, Cardiopulmonary Bypass, Liver Surgery and Trauma Surgery for the Years 2015, 2025 & 2030
  • TABLE 263: Middle East Recent Past, Current & Future Analysis for Thromboelastography by End-user - Hospitals, Blood Banks, Academic Institutes and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Middle East Historic Review for Thromboelastography by End-user - Hospitals, Blood Banks, Academic Institutes and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 265: Middle East 15-Year Perspective for Thromboelastography by End-user - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Academic Institutes and Other End-Users for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 266: Iran Recent Past, Current & Future Analysis for Thromboelastography by Type - Standard, Rapid TEG, Native TEG, Heparinase, Functional Fibrinogen and Platelet Mapping - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Iran Historic Review for Thromboelastography by Type - Standard, Rapid TEG, Native TEG, Heparinase, Functional Fibrinogen and Platelet Mapping Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 268: Iran 15-Year Perspective for Thromboelastography by Type - Percentage Breakdown of Value Sales for Standard, Rapid TEG, Native TEG, Heparinase, Functional Fibrinogen and Platelet Mapping for the Years 2015, 2025 & 2030
  • TABLE 269: Iran Recent Past, Current & Future Analysis for Thromboelastography by Application - Obstetrics, Cardiopulmonary Bypass, Liver Surgery and Trauma Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Iran Historic Review for Thromboelastography by Application - Obstetrics, Cardiopulmonary Bypass, Liver Surgery and Trauma Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 271: Iran 15-Year Perspective for Thromboelastography by Application - Percentage Breakdown of Value Sales for Obstetrics, Cardiopulmonary Bypass, Liver Surgery and Trauma Surgery for the Years 2015, 2025 & 2030
  • TABLE 272: Iran Recent Past, Current & Future Analysis for Thromboelastography by End-user - Hospitals, Blood Banks, Academic Institutes and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Iran Historic Review for Thromboelastography by End-user - Hospitals, Blood Banks, Academic Institutes and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 274: Iran 15-Year Perspective for Thromboelastography by End-user - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Academic Institutes and Other End-Users for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 275: Israel Recent Past, Current & Future Analysis for Thromboelastography by Type - Standard, Rapid TEG, Native TEG, Heparinase, Functional Fibrinogen and Platelet Mapping - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Israel Historic Review for Thromboelastography by Type - Standard, Rapid TEG, Native TEG, Heparinase, Functional Fibrinogen and Platelet Mapping Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 277: Israel 15-Year Perspective for Thromboelastography by Type - Percentage Breakdown of Value Sales for Standard, Rapid TEG, Native TEG, Heparinase, Functional Fibrinogen and Platelet Mapping for the Years 2015, 2025 & 2030
  • TABLE 278: Israel Recent Past, Current & Future Analysis for Thromboelastography by Application - Obstetrics, Cardiopulmonary Bypass, Liver Surgery and Trauma Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Israel Historic Review for Thromboelastography by Application - Obstetrics, Cardiopulmonary Bypass, Liver Surgery and Trauma Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 280: Israel 15-Year Perspective for Thromboelastography by Application - Percentage Breakdown of Value Sales for Obstetrics, Cardiopulmonary Bypass, Liver Surgery and Trauma Surgery for the Years 2015, 2025 & 2030
  • TABLE 281: Israel Recent Past, Current & Future Analysis for Thromboelastography by End-user - Hospitals, Blood Banks, Academic Institutes and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Israel Historic Review for Thromboelastography by End-user - Hospitals, Blood Banks, Academic Institutes and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 283: Israel 15-Year Perspective for Thromboelastography by End-user - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Academic Institutes and Other End-Users for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 284: Saudi Arabia Recent Past, Current & Future Analysis for Thromboelastography by Type - Standard, Rapid TEG, Native TEG, Heparinase, Functional Fibrinogen and Platelet Mapping - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Saudi Arabia Historic Review for Thromboelastography by Type - Standard, Rapid TEG, Native TEG, Heparinase, Functional Fibrinogen and Platelet Mapping Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 286: Saudi Arabia 15-Year Perspective for Thromboelastography by Type - Percentage Breakdown of Value Sales for Standard, Rapid TEG, Native TEG, Heparinase, Functional Fibrinogen and Platelet Mapping for the Years 2015, 2025 & 2030
  • TABLE 287: Saudi Arabia Recent Past, Current & Future Analysis for Thromboelastography by Application - Obstetrics, Cardiopulmonary Bypass, Liver Surgery and Trauma Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 288: Saudi Arabia Historic Review for Thromboelastography by Application - Obstetrics, Cardiopulmonary Bypass, Liver Surgery and Trauma Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 289: Saudi Arabia 15-Year Perspective for Thromboelastography by Application - Percentage Breakdown of Value Sales for Obstetrics, Cardiopulmonary Bypass, Liver Surgery and Trauma Surgery for the Years 2015, 2025 & 2030
  • TABLE 290: Saudi Arabia Recent Past, Current & Future Analysis for Thromboelastography by End-user - Hospitals, Blood Banks, Academic Institutes and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 291: Saudi Arabia Historic Review for Thromboelastography by End-user - Hospitals, Blood Banks, Academic Institutes and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 292: Saudi Arabia 15-Year Perspective for Thromboelastography by End-user - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Academic Institutes and Other End-Users for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 293: UAE Recent Past, Current & Future Analysis for Thromboelastography by Type - Standard, Rapid TEG, Native TEG, Heparinase, Functional Fibrinogen and Platelet Mapping - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 294: UAE Historic Review for Thromboelastography by Type - Standard, Rapid TEG, Native TEG, Heparinase, Functional Fibrinogen and Platelet Mapping Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 295: UAE 15-Year Perspective for Thromboelastography by Type - Percentage Breakdown of Value Sales for Standard, Rapid TEG, Native TEG, Heparinase, Functional Fibrinogen and Platelet Mapping for the Years 2015, 2025 & 2030
  • TABLE 296: UAE Recent Past, Current & Future Analysis for Thromboelastography by Application - Obstetrics, Cardiopulmonary Bypass, Liver Surgery and Trauma Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 297: UAE Historic Review for Thromboelastography by Application - Obstetrics, Cardiopulmonary Bypass, Liver Surgery and Trauma Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 298: UAE 15-Year Perspective for Thromboelastography by Application - Percentage Breakdown of Value Sales for Obstetrics, Cardiopulmonary Bypass, Liver Surgery and Trauma Surgery for the Years 2015, 2025 & 2030
  • TABLE 299: UAE Recent Past, Current & Future Analysis for Thromboelastography by End-user - Hospitals, Blood Banks, Academic Institutes and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 300: UAE Historic Review for Thromboelastography by End-user - Hospitals, Blood Banks, Academic Institutes and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 301: UAE 15-Year Perspective for Thromboelastography by End-user - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Academic Institutes and Other End-Users for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 302: Rest of Middle East Recent Past, Current & Future Analysis for Thromboelastography by Type - Standard, Rapid TEG, Native TEG, Heparinase, Functional Fibrinogen and Platelet Mapping - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Rest of Middle East Historic Review for Thromboelastography by Type - Standard, Rapid TEG, Native TEG, Heparinase, Functional Fibrinogen and Platelet Mapping Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 304: Rest of Middle East 15-Year Perspective for Thromboelastography by Type - Percentage Breakdown of Value Sales for Standard, Rapid TEG, Native TEG, Heparinase, Functional Fibrinogen and Platelet Mapping for the Years 2015, 2025 & 2030
  • TABLE 305: Rest of Middle East Recent Past, Current & Future Analysis for Thromboelastography by Application - Obstetrics, Cardiopulmonary Bypass, Liver Surgery and Trauma Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Rest of Middle East Historic Review for Thromboelastography by Application - Obstetrics, Cardiopulmonary Bypass, Liver Surgery and Trauma Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 307: Rest of Middle East 15-Year Perspective for Thromboelastography by Application - Percentage Breakdown of Value Sales for Obstetrics, Cardiopulmonary Bypass, Liver Surgery and Trauma Surgery for the Years 2015, 2025 & 2030
  • TABLE 308: Rest of Middle East Recent Past, Current & Future Analysis for Thromboelastography by End-user - Hospitals, Blood Banks, Academic Institutes and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 309: Rest of Middle East Historic Review for Thromboelastography by End-user - Hospitals, Blood Banks, Academic Institutes and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 310: Rest of Middle East 15-Year Perspective for Thromboelastography by End-user - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Academic Institutes and Other End-Users for the Years 2015, 2025 & 2030
• AFRICA
  • Thromboelastography Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 311: Africa Recent Past, Current & Future Analysis for Thromboelastography by Type - Standard, Rapid TEG, Native TEG, Heparinase, Functional Fibrinogen and Platelet Mapping - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 312: Africa Historic Review for Thromboelastography by Type - Standard, Rapid TEG, Native TEG, Heparinase, Functional Fibrinogen and Platelet Mapping Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 313: Africa 15-Year Perspective for Thromboelastography by Type - Percentage Breakdown of Value Sales for Standard, Rapid TEG, Native TEG, Heparinase, Functional Fibrinogen and Platelet Mapping for the Years 2015, 2025 & 2030
  • TABLE 314: Africa Recent Past, Current & Future Analysis for Thromboelastography by Application - Obstetrics, Cardiopulmonary Bypass, Liver Surgery and Trauma Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 315: Africa Historic Review for Thromboelastography by Application - Obstetrics, Cardiopulmonary Bypass, Liver Surgery and Trauma Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 316: Africa 15-Year Perspective for Thromboelastography by Application - Percentage Breakdown of Value Sales for Obstetrics, Cardiopulmonary Bypass, Liver Surgery and Trauma Surgery for the Years 2015, 2025 & 2030
  • TABLE 317: Africa Recent Past, Current & Future Analysis for Thromboelastography by End-user - Hospitals, Blood Banks, Academic Institutes and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 318: Africa Historic Review for Thromboelastography by End-user - Hospitals, Blood Banks, Academic Institutes and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 319: Africa 15-Year Perspective for Thromboelastography by End-user - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Academic Institutes and Other End-Users for the Years 2015, 2025 & 2030

IV. COMPETITION